Prostate Cancer Treatment Market Size, Share, Trends, Industry Analysis Report: By Drug Class (Hormonal Therapy, Chemotherapy, Immunotherapy, Targeted Therapy, and Others), Distribution Channel, and Region (North America, Europe, Asia Pacific, Latin Ameri
Description
The prostate cancer treatment market size is expected to reach USD 31.60 billion by 2034, according to a new study by Polaris Market Research. The report “Prostate Cancer Treatment Market Size, Share, Trends, Industry Analysis Report: By Drug Class (Hormonal Therapy, Chemotherapy, Immunotherapy, Targeted Therapy, and Others), Distribution Channel, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The prostate cancer treatment market growth is attributed to the rising prevalence of prostate cancer, especially among aging populations, and advancements in diagnostic and therapeutic technologies. Key drivers include the increasing adoption of precision medicine; the development of innovative therapies such as immunotherapy, targeted therapy, and radiopharmaceuticals; and the growing focus on early diagnosis and screening. Prostate cancer treatment market opportunities lie in the expansion of digital health solutions, including telemedicine and e-prescriptions, which improve patient accessibility to treatments. Trends such as the adoption of combination therapies and minimally invasive procedures and the use of biomarkers for personalized treatments are shaping the market’s future. As the global incidence of prostate cancer rises, the market is expected to grow significantly during the forecast period, with regions such as North America and Asia Pacific driving much of the expansion.
Prostate Cancer Treatment Market Report Highlights:
By drug class, the hormonal therapy segment holds the largest prostate cancer treatment market share due to its widespread use in treating advanced prostate cancer. However, the targeted therapy segment is expected to register the highest growth, driven by the increasing adoption of precision medicine and novel treatment options.
By distribution channel, the hospital pharmacies segment dominates the prostate cancer treatment market revenue share, primarily due to their role in dispensing specialized treatments, especially for advanced cancer. However, the online pharmacies segment is witnessing the highest growth, fueled by the rise of digital health platforms and the convenience of home delivery.
North America dominates the global market, with its high prostate cancer incidence and access to innovative therapies. However, the Asia Pacific market is experiencing the highest growth, driven by improved healthcare infrastructure and rising awareness about prostate cancer in countries such as China and India.
Polaris Market Research has segmented the prostate cancer treatment market report on the basis of drug class, distribution channel, and region:
By Drug Class Outlook (Revenue – USD Billion, 2020–2034)
Hormonal Therapy
Chemotherapy
Immunotherapy
Targeted Therapy
Others
By Distribution Channel Outlook (Revenue – USD Billion, 2020–2034)
Hospital Pharmacies
Drug Stores & Retail Pharmacies
Online Pharmacies
By Regional Outlook (Revenue – USD Billion, 2020–2034)
North America
The prostate cancer treatment market growth is attributed to the rising prevalence of prostate cancer, especially among aging populations, and advancements in diagnostic and therapeutic technologies. Key drivers include the increasing adoption of precision medicine; the development of innovative therapies such as immunotherapy, targeted therapy, and radiopharmaceuticals; and the growing focus on early diagnosis and screening. Prostate cancer treatment market opportunities lie in the expansion of digital health solutions, including telemedicine and e-prescriptions, which improve patient accessibility to treatments. Trends such as the adoption of combination therapies and minimally invasive procedures and the use of biomarkers for personalized treatments are shaping the market’s future. As the global incidence of prostate cancer rises, the market is expected to grow significantly during the forecast period, with regions such as North America and Asia Pacific driving much of the expansion.
Prostate Cancer Treatment Market Report Highlights:
By drug class, the hormonal therapy segment holds the largest prostate cancer treatment market share due to its widespread use in treating advanced prostate cancer. However, the targeted therapy segment is expected to register the highest growth, driven by the increasing adoption of precision medicine and novel treatment options.
By distribution channel, the hospital pharmacies segment dominates the prostate cancer treatment market revenue share, primarily due to their role in dispensing specialized treatments, especially for advanced cancer. However, the online pharmacies segment is witnessing the highest growth, fueled by the rise of digital health platforms and the convenience of home delivery.
North America dominates the global market, with its high prostate cancer incidence and access to innovative therapies. However, the Asia Pacific market is experiencing the highest growth, driven by improved healthcare infrastructure and rising awareness about prostate cancer in countries such as China and India.
Polaris Market Research has segmented the prostate cancer treatment market report on the basis of drug class, distribution channel, and region:
By Drug Class Outlook (Revenue – USD Billion, 2020–2034)
Hormonal Therapy
Chemotherapy
Immunotherapy
Targeted Therapy
Others
By Distribution Channel Outlook (Revenue – USD Billion, 2020–2034)
Hospital Pharmacies
Drug Stores & Retail Pharmacies
Online Pharmacies
By Regional Outlook (Revenue – USD Billion, 2020–2034)
North America
- US
- Canada
- Germany
- France
- UK
- Italy
- Spain
- Netherlands
- Russia
- Rest of Europe
- China
- Japan
- India
- Malaysia
- South Korea
- Indonesia
- Australia
- Vietnam
- Rest of Asia Pacific
- Saudi Arabia
- UAE
- Israel
- South Africa
- Rest of Middle East & Africa
- Mexico
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
118 Pages
- 1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
- 2. Executive Summary
- 2.1. Market Highlights
- 3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
- 4. Global Prostate Cancer Treatment Market Insights
- 4.1. Prostate Cancer Treatment Market – Market Snapshot
- 4.2. Prostate Cancer Treatment Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Increasing Prevalence of Prostate Cancer
- 4.2.1.2. Advances in Diagnostic and Therapeutic Technologies
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High Cost of Treatment
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Prostate Cancer Treatment Market Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
- 5. Global Prostate Cancer Treatment Market, by Drug Class
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Prostate Cancer Treatment Market, by Drug Class, 2020-2034 (USD Billion)
- 5.3. Hormonal Therapy
- 5.3.1. Global Prostate Cancer Treatment Market, by Hormonal Therapy, by Region, 2020-2034 (USD Billion)
- 5.4. Chemotherapy
- 5.4.1. Global Prostate Cancer Treatment Market, by Chemotherapy, by Region, 2020-2034 (USD Billion)
- 5.5. Immunotherapy
- 5.5.1. Global Prostate Cancer Treatment Market, by Immunotherapy, by Region, 2020-2034 (USD Billion)
- 5.6. Targeted Therapy
- 5.6.1. Global Prostate Cancer Treatment Market, by Targeted Therapy, by Region, 2020-2034 (USD Billion)
- 5.7. Others
- 5.7.1. Global Prostate Cancer Treatment Market, by Others, by Region, 2020-2034 (USD Billion)
- 6. Global Prostate Cancer Treatment Market, by Distribution Channel
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Prostate Cancer Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 6.3. Hospital Pharmacies
- 6.3.1. Global Prostate Cancer Treatment Market, by Hospital Pharmacies, by Region, 2020-2034 (USD Billion)
- 6.4. Drug Stores & Retail Pharmacies
- 6.4.1. Global Prostate Cancer Treatment Market, by Drug Stores & Retail Pharmacies, by Region, 2020-2034 (USD Billion)
- 6.5. Online Pharmacies
- 6.5.1. Global Prostate Cancer Treatment Market, by Online Pharmacies, by Region, 2020-2034 (USD Billion)
- 7. Global Prostate Cancer Treatment Market, by Geography
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Prostate Cancer Treatment Market Assessment, By Geography, 2020-2034 (USD Billion)
- 7.3. Prostate Cancer Treatment Market – North America
- 7.3.1. North America: Prostate Cancer Treatment Market, by Drug Class, 2020-2034 (USD Billion)
- 7.3.2. North America: Prostate Cancer Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 7.3.3. Prostate Cancer Treatment Market – U.S.
- 7.3.3.1. U.S.: Prostate Cancer Treatment Market, by Drug Class, 2020-2034 (USD Billion)
- 7.3.3.2. U.S.: Prostate Cancer Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 7.3.4. Prostate Cancer Treatment Market – Canada
- 7.3.4.1. Canada: Prostate Cancer Treatment Market, by Drug Class, 2020-2034 (USD Billion)
- 7.3.4.2. Canada: Prostate Cancer Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 7.4. Prostate Cancer Treatment Market – Europe
- 7.4.1. Europe: Prostate Cancer Treatment Market, by Drug Class, 2020-2034 (USD Billion)
- 7.4.2. Europe: Prostate Cancer Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 7.4.3. Prostate Cancer Treatment Market – UK
- 7.4.3.1. UK: Prostate Cancer Treatment Market, by Drug Class, 2020-2034 (USD Billion)
- 7.4.3.2. UK: Prostate Cancer Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 7.4.4. Prostate Cancer Treatment Market – France
- 7.4.4.1. France: Prostate Cancer Treatment Market, by Drug Class, 2020-2034 (USD Billion)
- 7.4.4.2. France: Prostate Cancer Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 7.4.5. Prostate Cancer Treatment Market – Germany
- 7.4.5.1. Germany: Prostate Cancer Treatment Market, by Drug Class, 2020-2034 (USD Billion)
- 7.4.5.2. Germany: Prostate Cancer Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 7.4.6. Prostate Cancer Treatment Market – Italy
- 7.4.6.1. Italy: Prostate Cancer Treatment Market, by Drug Class, 2020-2034 (USD Billion)
- 7.4.6.2. Italy: Prostate Cancer Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 7.4.7. Prostate Cancer Treatment Market – Spain
- 7.4.7.1. Spain: Prostate Cancer Treatment Market, by Drug Class, 2020-2034 (USD Billion)
- 7.4.7.2. Spain: Prostate Cancer Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 7.4.8. Prostate Cancer Treatment Market – Netherlands
- 7.4.8.1. Netherlands: Prostate Cancer Treatment Market, by Drug Class, 2020-2034 (USD Billion)
- 7.4.8.2. Netherlands: Prostate Cancer Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 7.4.9. Prostate Cancer Treatment Market – Russia
- 7.4.9.1. Russia: Prostate Cancer Treatment Market, by Drug Class, 2020-2034 (USD Billion)
- 7.4.9.2. Russia: Prostate Cancer Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 7.4.10. Prostate Cancer Treatment Market – Rest of Europe
- 7.4.10.1. Rest of Europe: Prostate Cancer Treatment Market, by Drug Class, 2020-2034 (USD Billion)
- 7.4.10.2. Rest of Europe: Prostate Cancer Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 7.5. Prostate Cancer Treatment Market – Asia Pacific
- 7.5.1. Asia Pacific: Prostate Cancer Treatment Market, by Drug Class, 2020-2034 (USD Billion)
- 7.5.2. Asia Pacific: Prostate Cancer Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 7.5.3. Prostate Cancer Treatment Market – China
- 7.5.3.1. China: Prostate Cancer Treatment Market, by Drug Class, 2020-2034 (USD Billion)
- 7.5.3.2. China: Prostate Cancer Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 7.5.4. Prostate Cancer Treatment Market – India
- 7.5.4.1. India: Prostate Cancer Treatment Market, by Drug Class, 2020-2034 (USD Billion)
- 7.5.4.2. India: Prostate Cancer Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 7.5.5. Prostate Cancer Treatment Market – Malaysia
- 7.5.5.1. Malaysia: Prostate Cancer Treatment Market, by Drug Class, 2020-2034 (USD Billion)
- 7.5.5.2. Malaysia: Prostate Cancer Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 7.5.6. Prostate Cancer Treatment Market – Japan
- 7.5.6.1. Japan: Prostate Cancer Treatment Market, by Drug Class, 2020-2034 (USD Billion)
- 7.5.6.2. Japan: Prostate Cancer Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 7.5.7. Prostate Cancer Treatment Market – Indonesia
- 7.5.7.1. Indonesia: Prostate Cancer Treatment Market, by Drug Class, 2020-2034 (USD Billion)
- 7.5.7.2. Indonesia: Prostate Cancer Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 7.5.8. Prostate Cancer Treatment Market – South Korea
- 7.5.8.1. South Korea: Prostate Cancer Treatment Market, by Drug Class, 2020-2034 (USD Billion)
- 7.5.8.2. South Korea: Prostate Cancer Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 7.5.9. Prostate Cancer Treatment Market – Australia
- 7.5.9.1. Australia: Prostate Cancer Treatment Market, by Drug Class, 2020-2034 (USD Billion)
- 7.5.9.2. Australia: Prostate Cancer Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 7.5.10. Prostate Cancer Treatment Market – Rest of Asia Pacific
- 7.5.10.1. Rest of Asia Pacific: Prostate Cancer Treatment Market, by Drug Class, 2020-2034 (USD Billion)
- 7.5.10.2. Rest of Asia Pacific: Prostate Cancer Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 7.6. Prostate Cancer Treatment Market – Middle East & Africa
- 7.6.1. Middle East & Africa: Prostate Cancer Treatment Market, by Drug Class, 2020-2034 (USD Billion)
- 7.6.2. Middle East & Africa: Prostate Cancer Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 7.6.3. Prostate Cancer Treatment Market – Saudi Arabia
- 7.6.3.1. Saudi Arabia: Prostate Cancer Treatment Market, by Drug Class, 2020-2034 (USD Billion)
- 7.6.3.2. Saudi Arabia: Prostate Cancer Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 7.6.4. Prostate Cancer Treatment Market – UAE
- 7.6.4.1. UAE: Prostate Cancer Treatment Market, by Drug Class, 2020-2034 (USD Billion)
- 7.6.4.2. UAE: Prostate Cancer Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 7.6.5. Prostate Cancer Treatment Market – Israel
- 7.6.5.1. Israel: Prostate Cancer Treatment Market, by Drug Class, 2020-2034 (USD Billion)
- 7.6.5.2. Israel: Prostate Cancer Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 7.6.6. Prostate Cancer Treatment Market – South Africa
- 7.6.6.1. South Africa: Prostate Cancer Treatment Market, by Drug Class, 2020-2034 (USD Billion)
- 7.6.6.2. South Africa: Prostate Cancer Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 7.6.7. Prostate Cancer Treatment Market – Rest of Middle East & Africa
- 7.6.7.1. Rest of Middle East & Africa: Prostate Cancer Treatment Market, by Drug Class, 2020-2034 (USD Billion)
- 7.6.7.2. Rest of Middle East & Africa: Prostate Cancer Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 7.7. Prostate Cancer Treatment Market – Latin America
- 7.7.1. Latin America: Prostate Cancer Treatment Market, by Drug Class, 2020-2034 (USD Billion)
- 7.7.2. Latin America: Prostate Cancer Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 7.7.3. Prostate Cancer Treatment Market – Mexico
- 7.7.3.1. Mexico: Prostate Cancer Treatment Market, by Drug Class, 2020-2034 (USD Billion)
- 7.7.3.2. Mexico: Prostate Cancer Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 7.7.4. Prostate Cancer Treatment Market – Brazil
- 7.7.4.1. Brazil: Prostate Cancer Treatment Market, by Drug Class, 2020-2034 (USD Billion)
- 7.7.4.2. Brazil: Prostate Cancer Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 7.7.5. Prostate Cancer Treatment Market – Argentina
- 7.7.5.1. Argentina: Prostate Cancer Treatment Market, by Drug Class, 2020-2034 (USD Billion)
- 7.7.5.2. Argentina: Prostate Cancer Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 7.7.6. Prostate Cancer Treatment Market – Rest of Latin America
- 7.7.6.1. Rest of Latin America: Prostate Cancer Treatment Market, by Drug Class, 2020-2034 (USD Billion)
- 7.7.6.2. Rest of Latin America: Prostate Cancer Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8. Competitive Landscape
- 8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
- 8.2. Partnerships/Collaborations/Agreements/Exhibitions
- 9. Company Profiles
- 9.1. Johnson & Johnson Services, Inc.
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.1.4. Recent Development
- 9.2. Astellas Pharma Inc.
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.2.4. Recent Development
- 9.3. Sanofi
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.3.4. Recent Development
- 9.4. Pfizer Inc.
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.4.4. Recent Development
- 9.5. AstraZeneca Plc
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.5.4. Recent Development
- 9.6. Bayer AG
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.6.4. Recent Development
- 9.7. AbbVie Inc.
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.7.4. Recent Development
- 9.8. Amgen Inc.
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.8.4. Recent Development
- 9.9. Dendreon Pharmaceuticals LLC
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.9.4. Recent Development
- 9.10. Endo Pharmaceuticals Inc.
- 9.10.1. Company Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Benchmarking
- 9.10.4. Recent Development
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
